Type 2 Diabetic Sepsis Patients Have a Lower Mortality Rate in Pioglitazone Use: A Nationwide 15-Year Propensity Score Matching Observational Study in Taiwan

BACKGROUND: Pioglitazone use via the PPARγ agonist in sepsis patients is inconclusive. It was based on a great number of animal studies. However, except for information from animal studies, there are merely any data of human studies for reference. METHODS: This study was conducted by a unique databa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Ming-Shun, Hu, Sung-Yuan, Liao, Shu-Hui, Chang, Chia-Ming, Hsieh, Vivian Chia-Rong, How, Chorng-Kuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363455/
https://www.ncbi.nlm.nih.gov/pubmed/34394992
http://dx.doi.org/10.1155/2021/4916777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363455/
https://www.ncbi.nlm.nih.gov/pubmed/34394992
http://dx.doi.org/10.1155/2021/4916777

Ejemplares similares